NATIONAL BLOOD NETWORK

ICR 198609-2070-006

OMB: 2070-0087

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC ID
Document
Title
Status
139969 Migrated
ICR Details
2070-0087 198609-2070-006
Historical Active
EPA/OCSPP
NATIONAL BLOOD NETWORK
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 12/16/1986
Retrieve Notice of Action (NOA) 09/19/1986
Since the blood analysis contemplated in the National Blood Netword cannot be readily incorporated into HHS's NHANE study, OMB is approvin the NBN for two years to allow EPA to conduct the pilot study and gain one year of field experience. In the two year time period EPA must answer the following questions about the practical utility of the NBN: (1) how does combining individual blood samples affect EPA's ability t track routes of exposure? (2) how does the blood donor population compare to the general population? and (3) can EPA translate chemical concentrations in blood to estimates of health risks? If the two year study demonstrates that the blood analysis contemplated by the NBN is feasible, EPA should again consult with HHS in order to incorporate the NBN analysis into NHANES. NHANES is preferable to the NBN because NHANES provides for a representative nationwide sample and collects a significant amount of background information on the study participants This will allow EPA and HHS to better trace routes of exposure. If EPA resubmits the NBN for approval it must document the practical effects of the NBN information on the Agency's priorities. For exampl how would the NBN help the Agency better target its resources to chemicals of concern. In addition, should answer whether the NBN can be substituted for the human adipose tissue survey and/or perform the surveys on alternate years.
  Inventory as of this Action Requested Previously Approved
11/30/1988 11/30/1988
4,500 0 0
1,500 0 0
0 0 0

TO IDENTIFY THE PREVALENCES AND LEVELS OF TOXIC SUBSTANCES IN HUMAN BLOOD TO SUPPORT OTS' TEST RULES AND EXISTING CHEMICALS ASSESSMENT PROGRAMS. ALSO BASELINE AND TREND INFORMATION ON THESE COMPOUNDS WILL BE DEVELOPED FOR THE GENERAL POPULATION AND SELECTED DEMOGRAPHIC AND GEOGRAPHIC SUBPOPULATIONS.

None
None


No

1
IC Title Form No. Form Name
NATIONAL BLOOD NETWORK 1201

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 4,500 0 0 4,500 0 0
Annual Time Burden (Hours) 1,500 0 0 1,500 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/19/1986


© 2024 OMB.report | Privacy Policy